Consistent with this finding, group 4 patients show decreased CRP levels compared to all other groups (Fig. 2a) and an increased frequency of peripheral vascular diseases and a slightly higher age of stroke (Fig. 5c,e). This evidence concerns the gene CRP and peripheral vascular disease.